Phase 3 Trial

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Phase 3 Trial

Aug 6, 2024, 02:02 | Insight

Trastuzumab deruxtecan therapy in patients with HER2-positive metastatic breast cancer

Francisco Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…

Jul 19, 2024, 22:56 | Insight

Stunning interim clinical trial data from Revolution Medicines

Grainne O'Kane, Medical Oncologist at Princess Margaret Cancer Centre, shared a post by Kenneth Olive,…

Jul 2, 2024, 08:18 | Blog

Naveen Pemmaraju: Navitoclax and Ruxolitinib in Patients With Untreated Myelofibrosis

Naveen Pemmaraju shared a post on LinkedIn: “A huge shout out to all of you…

Jun 27, 2024, 11:10 | Blog

Press release from the PRESERVE 2 phase 3 trial

Paolo Tarantino shared a post on X: “Press release from the PRESERVE 2 phase 3…

May 2, 2024, 11:41 | Insight

Erman Akkus summarizes Adjuvant Aspirin in Breast Cancer

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Adjuvant Aspirin in Breast Cancer…

May 1, 2024, 13:41 | Opinion

Sara Tolaney: Such an important question addressed in the Alliance A011502 study

Sara Tolaney shared a post by Erman Akkus, Medical Oncology Fellow at Ankara University, on X/Twitter: "Such…

Mar 4, 2024, 17:58 | Insight

Paolo Tarantino: You don’t always need a fancy new drug to impact patients QoL

Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…

All: 7 Posts: 1 - 100